captopril has been researched along with Acute Confusional Senile Dementia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ros Forteza, FJ | 1 |
| Hiraga, S; Komano, H; Liu, J; Liu, S; Maeda, T; Michikawa, M; Takahashi, S; Tanabe, C; Terayama, Y; Watanabe, A; Zou, K | 1 |
| AbdAlla, S; Fu, X; Langer, A; Quitterer, U | 1 |
| AbdAlla, S; Abdelbaset, A; El Hakim, A; Elfaramawy, Y; Quitterer, U | 1 |
| Farris, W; Hemming, ML; Selkoe, DJ | 1 |
| Barnes, NM; Cheng, CH; Costall, B; Naylor, RJ; Williams, TJ; Wischik, CM | 1 |
6 other study(ies) available for captopril and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Alzheimer disease triggered by reversible posterior leukoencephalopathy syndrome.
Topics: Acetaminophen; Aged; Alzheimer Disease; Analgesics, Non-Narcotic; Antihypertensive Agents; Captopril; Diuretics; Female; Furosemide; Headache; Humans; Hypertension; Magnetic Resonance Imaging; Photophobia; Posterior Leukoencephalopathy Syndrome; Sex Factors; Spain | 2020 |
Aβ43 is the earliest-depositing Aβ species in APP transgenic mouse brain and is converted to Aβ41 by two active domains of ACE.
Topics: Aged; Aging; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Brain; Captopril; Case-Control Studies; Disease Progression; Humans; Mice; Mice, Transgenic; Mutation; Peptide Fragments; Peptidyl-Dipeptidase A; Presenilins | 2013 |
ACE inhibition with captopril retards the development of signs of neurodegeneration in an animal model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Disease Models, Animal; Hippocampus; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nerve Regeneration; Oligonucleotide Array Sequence Analysis; Oxidation-Reduction; Plaque, Amyloid; Protein Transport; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Transcriptome; Up-Regulation | 2013 |
Inhibition of ACE Retards Tau Hyperphosphorylation and Signs of Neuronal Degeneration in Aged Rats Subjected to Chronic Mild Stress.
Topics: Alzheimer Disease; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; gamma-Synuclein; Gene Expression Regulation; Glutamate Decarboxylase; Hippocampus; Humans; Microtubule-Associated Proteins; Nerve Degeneration; Neurons; Peptidyl-Dipeptidase A; Phosphorylation; Rats; tau Proteins | 2015 |
Effects of prolonged angiotensin-converting enzyme inhibitor treatment on amyloid beta-protein metabolism in mouse models of Alzheimer disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Angiotensin-Converting Enzyme Inhibitors; Animals; Brain Chemistry; Captopril; Enzyme-Linked Immunosorbent Assay; Humans; Image Interpretation, Computer-Assisted; Immunohistochemistry; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Transgenic; Neprilysin; Peptidyl-Dipeptidase A; Peripheral Nerves; Plaque, Amyloid | 2007 |
Angiotensin converting enzyme density is increased in temporal cortex from patients with Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cerebellum; Female; Frontal Lobe; Humans; Male; Organophosphorus Compounds; Peptidyl-Dipeptidase A; Proline; Temporal Lobe; Tritium | 1991 |